Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Truqap

Capivasertib

Open in the dashboard

Part D claims

2,165

Prescriptions dispensed, refills included

Drug cost

$46,107,035

Paid at the pharmacy, in all

Prescribers

145

With 11 or more claims of it

In 2024, Medicare Part D recorded 2,165 claims for Truqap (capivasertib) from 145 prescribers, at a total drug cost of $46.1 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 30 states and territories
Part D claims for Truqap by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 27 411 $8,959,315
FL 15 243 $5,186,410
NY 14 209 $4,444,137
PA 10 174 $3,802,960
TX 11 158 $3,294,806
MA 8 112 $2,441,479
NC 5 71 $1,471,208
OH 5 70 $1,556,277
IN 3 59 $1,240,095
TN 3 53 $1,054,685
SC 4 52 $907,908
KY 3 49 $980,788
IL 3 47 $898,607
GA 3 46 $982,713
CT 3 46 $1,017,246
The other 15 states and territories
State Prescribers Claims Drug cost
VA 3 43 $998,228
AL 3 39 $866,744
WA 3 36 $786,465
MN 3 36 $776,370
MO 2 35 $634,994
LA 3 35 $758,843
MI 2 27 $572,294
NJ 2 23 $513,016
OR 1 16 $362,538
OK 1 16 $291,057
CO 1 12 $268,462
MD 1 12 $269,106
AZ 1 12 $273,163
MT 1 12 $274,129
RI 1 11 $222,994

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 9 of 9
Part D claims for Truqap by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 86 1,280 $27,583,997
Medical Oncology 30 457 $9,382,799
Nurse Practitioner 8 135 $2,862,036
Internal Medicine 9 131 $2,783,712
Physician Assistant 4 53 $1,098,738
Hematology 3 44 $980,741
Pharmacist 3 40 $932,851
Diagnostic Radiology 1 13 $269,218
Hematopoietic Cell Transplantation and Cellular Therapy 1 12 $212,943

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Igor Makhlin Hematology-Oncology PA 54 $1,203,841 None on record
Jacqueline Bromberg Medical Oncology NY 34 $755,087 None on record
Rowena Meyer Nurse Practitioner CA 31 $684,668 None on record
Adnan Akhtar Hematology-Oncology FL 27 $611,447 None on record
Bilal Ansari Medical Oncology IN 27 $491,249 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record